Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 68

Sort by

Sort Order Select

Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.

https://doi.org/10.1182/hematology.2019000059

Published: 2019

Journal Articles

Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies

Richard J. Lin, Heidi D. Klepin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 59–62.

https://doi.org/10.1182/hematology.2019000076

Published: 2019

Journal Articles

Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice

Heidi D. Klepin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 53–58.

https://doi.org/10.1182/hematology.2019001299

Published: 2019

Journal Articles

Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care

Rebecca L. Olin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 63–70.

https://doi.org/10.1182/hematology.2019001300

Published: 2019

Journal Articles

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Jibran Durrani, Jaroslaw P. Maciejewski

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 97–104.

https://doi.org/10.1182/hematology.2019000019

Published: 2019

Journal Articles

Management of older Hodgkin lymphoma patients

Andrew M. Evens, Jordan Carter, Kah Poh Loh, Kevin A. David

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 233–242.

https://doi.org/10.1182/hematology.2019000028

Published: 2019

Journal Articles

Integrating patient-centered factors in the risk assessment of MDS

Rena J. Buckstein

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 373–380.

https://doi.org/10.1182/hematology.2019000041

Published: 2019

Journal Articles

Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist

Tanya M. Wildes, Kenneth C. Anderson

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 88–96.

https://doi.org/10.1182/asheducation-2018.1.88

Published: 2018

Journal Articles

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Daria V. Babushok

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 457–466.

https://doi.org/10.1182/asheducation-2018.1.457

Published: 2018

Journal Articles

Long-term complications in adolescent and young adult leukemia survivors

K. Scott Baker, Karen L. Syrjala

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 146–153.

https://doi.org/10.1182/asheducation-2018.1.146

Published: 2018

Journal Articles

Adolescent angst: enrollment on clinical trials

Theresa H. M. Keegan, Helen M. Parsons

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 154–160.

https://doi.org/10.1182/asheducation-2018.1.154

Published: 2018

Journal Articles

Selecting Frontline Therapy for CLL in 2018

Nitin Jain

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 242–247.

https://doi.org/10.1182/asheducation-2018.1.242

Published: 2018

Journal Articles

Chronic organ failure in adult sickle cell disease

Elliott Vichinsky

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 435–439.

https://doi.org/10.1182/asheducation-2017.1.435

Published: 2017

Journal Articles

Management of multiple myeloma in the newly diagnosed patient

María-Victoria Mateos, Jesús F. San Miguel

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 498–507.

https://doi.org/10.1182/asheducation-2017.1.498

Published: 2017

Journal Articles

Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution

Nancy L. Bartlett

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 317–323.

https://doi.org/10.1182/asheducation-2017.1.317

Published: 2017

Journal Articles

Treatment of older patients with acute lymphoblastic leukemia

Nicola Gökbuget

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 573–579.

https://doi.org/10.1182/asheducation-2016.1.573

Published: 2016

Journal Articles

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Simon Rule

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 419–424.

https://doi.org/10.1182/asheducation-2016.1.419

Published: 2016

Journal Articles

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Marco Ruella, Pierre Soubeyran

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 432–436.

https://doi.org/10.1182/asheducation-2016.1.432

Published: 2016

Journal Articles

Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction

Arati V. Rao

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 339–347.

https://doi.org/10.1182/asheducation-2016.1.339

Published: 2016

Journal Articles

Biologic vs physiologic age in the transplant candidate

Andrew S. Artz

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 99–105.

https://doi.org/10.1182/asheducation-2016.1.99

Published: 2016

NARROW

Single-agent and combination biologics in acute myeloid leukemia

Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies

Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice

Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care

Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome

Management of older Hodgkin lymphoma patients

Integrating patient-centered factors in the risk assessment of MDS

Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Long-term complications in adolescent and young adult leukemia survivors

Adolescent angst: enrollment on clinical trials

Selecting Frontline Therapy for CLL in 2018

Chronic organ failure in adult sickle cell disease

Management of multiple myeloma in the newly diagnosed patient

Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution

Treatment of older patients with acute lymphoblastic leukemia

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction

Biologic vs physiologic age in the transplant candidate

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only